# A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.

> **NCT00720421** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** AZD7325
- **DRUG:** AZD7325
- **DRUG:** AZD7325
- **DRUG:** Lorazepam
- **DRUG:** Lorazepam

## Key facts

- **NCT ID:** NCT00720421
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2010-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00720421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00720421, "A Sedation/Cognition/Electroencephalogram (EEG) Study Using AZD7325 and Comparator.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00720421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*